Amedeo Smart

Free Medical Literature Service

 

Amedeo

Prostate Cancer
  Free Subscription

Articles published in
AJR Am J Roentgenol
    March 2024
  1. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
    Reply to "Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence".
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31168.
    >> Share

  2. TAKAHASHI T
    Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence.
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31070.
    >> Share

    February 2024
  3. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
    PI-RADS Upgrading Rules: Impact on Prostate Cancer Detection and Biopsy Avoidance of MRI-Directed Diagnostic Pathways.
    AJR Am J Roentgenol. 2024 Feb 14. doi: 10.2214/AJR.23.30611.
    >> Share

    January 2024
  4. LAWRENCE EM
    Editorial Comment: Similar Upgrade and Downgrade Rates Between PI-RADS Version 2.0 and Version 2.1.
    AJR Am J Roentgenol. 2024;222:e2330325.
    >> Share

    December 2023
  5. BIROSH A, Miranda ES, Breau RH, McInnes MDF, et al
    Multiparametric Versus Biparametric Prostate MRI: Comparison of NPV for Clinically Significant Prostate Cancer.
    AJR Am J Roentgenol. 2023 Dec 13. doi: 10.2214/AJR.23.30496.
    >> Share

    September 2023
  6. YILMAZ EC, Lin Y, Belue MJ, Harmon SA, et al
    PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy.
    AJR Am J Roentgenol. 2023 Sep 20. doi: 10.2214/AJR.23.29964.
    >> Share

    July 2023
  7. WU CJ
    Editorial Comment: MRI Improves Preoperative Prognosis Prediction in Patients With Prostate Cancer.
    AJR Am J Roentgenol. 2023 Jul 19. doi: 10.2214/AJR.23.29909.
    >> Share

  8. MERRIMAN KM, Harmon SA, Belue MJ, Yilmaz EC, et al
    Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.
    AJR Am J Roentgenol. 2023 Jul 5. doi: 10.2214/AJR.23.29609.
    >> Share

    June 2023
  9. SANMUGALINGAM N, Sushentsev N, Lee KL, Caglic I, et al
    The PRECISE Recommendations for Prostate MRI in Patients on Active Surveillance for Prostate Cancer: A Critical Review.
    AJR Am J Roentgenol. 2023 Jun 21. doi: 10.2214/AJR.23.29518.
    >> Share

    May 2023
  10. GOWDA NK
    Editorial Comment: Biopsy of Subcentimeter Pelvic and Retroperitoneal Lymph Nodes Is Safe and Diagnostic.
    AJR Am J Roentgenol. 2023;220:726.
    >> Share

  11. O'SHEA A, Iravani A, Saboury B, Jadvar H, et al
    Integrating Theranostics Into Patient Care Pathways: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2023;220:619-629.
    >> Share

    February 2023
  12. MARGOLIS DJA
    Editorial Comment: Posttreatment Prostate MRI Is Not "RAD"...It's "PIRRfect".
    AJR Am J Roentgenol. 2023 Feb 15. doi: 10.2214/AJR.23.29133.
    >> Share

  13. ABREU-GOMEZ J, Dias AB, Ghai S
    PI-RR: The Prostate Imaging for Recurrence Reporting System for MRI Assessment of Local Prostate Cancer Recurrence After Radiation Therapy or Radical Prostatectomy-A Review.
    AJR Am J Roentgenol. 2023 Feb 1. doi: 10.2214/AJR.22.28665.
    >> Share

    January 2023
  14. WARD RD, Purysko AS
    Beyond the AJR: Biparametric MRI-Based Prostate Cancer Screening-A Cost-Effective Alternative to PSA Screening and Standard Biopsy.
    AJR Am J Roentgenol. 2023 Jan 18. doi: 10.2214/AJR.23.29011.
    >> Share

  15. SINHA P, Lamonica DM
    Beyond the AJR: (99m)Tc-MDP Bone Scintigraphy-Has It Met Its Match?
    AJR Am J Roentgenol. 2023 Jan 11. doi: 10.2214/AJR.23.28978.
    >> Share

    December 2022
  16. KAPPLINGER JD, Lima LMF, Packard AT, Nathan MA, et al
    Safety and Efficacy of CT-Guided Percutaneous Biopsy of Suspicious Subcentimeter Pelvic and Retroperitoneal Lymph Nodes Detected by (11)C-Choline PET in Patients With Prostate Cancer.
    AJR Am J Roentgenol. 2022 Dec 7. doi: 10.2214/AJR.22.28321.
    >> Share

    September 2022
  17. AHLAWAT S, Debs P, Amini B, Lecouvet FE, et al
    Clinical Applications and Controversies of Whole-Body MRI: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2022 Sep 28. doi: 10.2214/AJR.22.28229.
    >> Share

    August 2022
  18. GHAI S, Perlis N
    Beyond the AJR: MRI-Guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer.
    AJR Am J Roentgenol. 2022 Aug 24. doi: 10.2214/AJR.22.28413.
    >> Share

    June 2022
  19. WOO S
    Editorial Comment: Time to Ditch Bone Scans for Prostate Cancer Workup in the Era of PSMA PET/CT?
    AJR Am J Roentgenol. 2022 Jun 29:11. doi: 10.2214/AJR.22.27867.
    >> Share

  20. DAS JP, Woo S
    Multiparametric Prostate MRI for Biochemical Failure in the Era of Targeted PET Radiotracers: Point-MRI May No Longer Be Needed in Patient Workup.
    AJR Am J Roentgenol. 2022 Jun 1. doi: 10.2214/AJR.22.27882.
    >> Share

  21. PECORARO M, Panebianco V
    Multiparametric Prostate MRI for Biochemical Failure in the Era of Targeted PET Radiotracers: Counterpoint-MRI Remains a Specific and Accessible Test for Targeted Management.
    AJR Am J Roentgenol. 2022 Jun 1. doi: 10.2214/AJR.22.28042.
    >> Share

    May 2022
  22. BARRETT T, Ghafoor S, Gupta RT, Kim CK, et al
    Prostate MRI Qualification: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27615.
    >> Share

  23. ZHU A, Hu JC
    Beyond the AJR: Racial Disparities in Prostate MRI Utilization.
    AJR Am J Roentgenol. 2022 May 4. doi: 10.2214/AJR.22.27889.
    >> Share

    April 2022
  24. ZHAO G, Ji B
    Head-to-Head Comparison of (68)Ga-PSMA-11 PET/CT and (99m)Tc-MDP Bone Scintigraphy for the Detection of Bone Metastases in Patients With Prostate Cancer: A Meta-Analysis.
    AJR Am J Roentgenol. 2022 Apr 20. doi: 10.2214/AJR.21.27323.
    >> Share

  25. YANO M
    Editorial Comment: What Is Prostate MRI Interpretation Experience?
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27781.
    >> Share

    March 2022
  26. SALKA BR, Shankar PR, Troost JP, Khalatbari S, et al
    Effect of Prostate MRI Interpretation Experience on PPV Using PI-RADS Version 2: A 6-Year Assessment Among Eight Fellowship-Trained Radiologists.
    AJR Am J Roentgenol. 2022 Mar 23. doi: 10.2214/AJR.22.27421.
    >> Share

  27. COSTA DN, Menard A, Moore CM, Tamada T, et al
    The Global Reading Room: MRI-Targeted Prostate Biopsy After Proctocolectomy.
    AJR Am J Roentgenol. 2022 Mar 16. doi: 10.2214/AJR.22.27619.
    >> Share

    December 2021
  28. CUOCOLO R
    Editorial Comment: Prostate Cancer Detection With Machine Learning-Still More Challenges Than Opportunities.
    AJR Am J Roentgenol. 2021 Dec 22. doi: 10.2214/AJR.21.27221.
    >> Share

  29. TURKBEY B, Haider MA
    Artificial Intelligence (AI) for Automated Cancer Detection on Prostate MRI: Opportunities and Ongoing Challenges, From the AJR Special Series on AI Applications.
    AJR Am J Roentgenol. 2021 Dec 8. doi: 10.2214/AJR.21.26917.
    >> Share

    November 2021
  30. GAN JM, Kikano EG, Smith DA, Rao S, et al
    Clinically Significant Prostate Cancer Detection After A Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26569.
    >> Share

    October 2021
  31. SEYFRIED N, Mahran A, Panda A, Obmann VC, et al
    Diagnostic Yield of Incremental Biopsy Cores and Second Lesion Sampling for In-Gantry MRI-Guided Prostate Biopsy.
    AJR Am J Roentgenol. 2021;217:908-918.
    >> Share

    August 2021
  32. SHRIKI J
    Editorial Comment: Directions for Further Literature on the Role of PET in Biochemical Recurrence of Prostate Cancer.
    AJR Am J Roentgenol. 2021 Aug 25. doi: 10.2214/AJR.21.26706.
    >> Share

  33. DUAN H, Baratto L, Hatami N, Liang T, et al
    Reduced Acquisition Time Per Bed Position for PET/MRI Using (68)Ga-RM2 or (68)Ga-PSMA11 in Patients With Prostate Cancer: A Retrospective Analysis.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.25961.
    >> Share

  34. PATRA A, Khasawneh H, Suman G, Nathan MA, et al
    Atypical Metastases in the Abdomen and Pelvis From Biochemically Recurrent Prostate Cancer: (11)C-Choline PET/CT Imaging With Multimodality Correlation.
    AJR Am J Roentgenol. 2021 Aug 4. doi: 10.2214/AJR.21.26426.
    >> Share

  35. GALGANO SJ, McConathy J
    Beyond the AJR: Integrating (18)F-Fluciclovine PET/CT Into Salvage Radiotherapy Planning for Recurrent Prostate Cancer Reduces Rates of Biochemical Failure (EMPIRE-1 Trial).
    AJR Am J Roentgenol. 2021 Aug 4. doi: 10.2214/AJR.21.26599.
    >> Share

    July 2021
  36. TURKBEY B
    Editorial Comment: MRI for Benign Prostatic Hyperplasia-An Underutilized Imaging Opportunity.
    AJR Am J Roentgenol. 2021 Jul 28. doi: 10.2214/AJR.21.26603.
    >> Share

  37. CHANG SD, Ghai S, Kim CK, Oto A, et al
    MRI-Targeted Prostate Biopsy Techniques: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2021 Jul 14. doi: 10.2214/AJR.21.26154.
    >> Share

  38. BHAYANA R, O'Shea A, Anderson MA, Bradley WR, et al
    PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists.
    AJR Am J Roentgenol. 2021;217:141-151.
    >> Share

    June 2021
  39. GAFFNEY CD, Cai P, Li D, Margolis D, et al
    Increasing Utilization of MRI Before Prostate Biopsy in Black and Non-Black Men: An Analysis of the SEER-Medicare Cohort.
    AJR Am J Roentgenol. 2021 Jun 23:1-6. doi: 10.2214/AJR.20.23462.
    >> Share

    May 2021
  40. WEI CG, Zhang YY, Pan P, Chen T, et al
    Diagnostic Accuracy and Interobserver Agreement of PI-RADS Version 2 and Version 2.1 for the Detection of Transition Zone Prostate Cancers.
    AJR Am J Roentgenol. 2021;216:1247-1256.
    >> Share

    April 2021
  41. DENIFFEL D, Haider MA
    Beyond the AJR: "Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study".
    AJR Am J Roentgenol. 2021 Apr 28. doi: 10.2214/AJR.21.26048.
    >> Share

  42. SCIALPI M, Scialpi P, Blasi AD
    Prostate Biparametric MRI: PI-RADS Committee Position and Perspectives.
    AJR Am J Roentgenol. 2021 Apr 21:W1. doi: 10.2214/AJR.21.25443.
    >> Share

  43. HUANG YH, Ozutemiz C, Rubin N, Schat R, et al
    Impact of 18 French Rectal Tube Placement on Image Quality of Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2021 Apr 14. doi: 10.2214/AJR.21.25732.
    >> Share

  44. TURKBEY B
    Beyond the AJR: "Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy with Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer A Phase 3 Randomized Clinical Trial".
    AJR Am J Roentgenol. 2021 Apr 7. doi: 10.2214/AJR.21.25954.
    >> Share

    March 2021
  45. PRINCE M, Foster BR, Kaempf A, Liu JJ, et al
    In-Bore Versus Fusion MRI-Targeted Prostate Biopsy of PI-RADS Category 4 or 5 Lesions: A Retrospective Comparative Analysis Using Propensity Score Weighting.
    AJR Am J Roentgenol. 2021 Mar 1. doi: 10.2214/AJR.20.25207.
    >> Share

    February 2021
  46. CHANG SD, Margolis DJA, Turkbey B, Arnold AA, et al
    Practice Patterns and Challenges of Performing and Interpreting Prostate MRI: A Survey by the Society of Abdominal Radiology Prostate Disease-Focused Panel.
    AJR Am J Roentgenol. 2021 Feb 10:1-8. doi: 10.2214/AJR.20.23256.
    >> Share

    July 2020
  47. GIGANTI F, Kirkham A, Allen C, Punwani S, et al
    Update on multiparametric prostate MRI during active surveillance: current and future trends and role of the PRECISE recommendations.
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23985.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016